SCHEMBL5773426

SCHEMBL5773426

CC1CCCCN1CCCN(CCCc1cnoc1-c1ccc(F)cc1)C(=O)C(F)(F)F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.41
SLC2A1 P11166 1/20 0.37
ALDH1A1 P00352 5/20 0.37
KDM4E B2RXH2 2/20 0.37
TSHR P16473 2/20 0.37
HSD17B10 Q99714 2/20 0.37
CYP3A4 P08684 1/20 0.37
HRH3 Q9Y5N1 5/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
LMNA P02545 1/20 0.37
CHRM2 P08172 1/20 0.36
CHRM4 P08173 1/20 0.36
HTR1A P08908 1/20 0.36
CHRM5 P08912 1/20 0.36
CHRM1 P11229 1/20 0.36
CHRM3 P20309 1/20 0.36
HRH2 P25021 1/20 0.36
HTR1D P28221 1/20 0.36
HTR2A P28223 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5774868 0.93 TRPV1 (0.38) ALDH1A1KDM4EHRH3SCN1ASCN2A
SCHEMBL5773778 0.84 PLA2G7 (0.36) ALDH1A1KDM4ETSHRCYP3A4HTR2A
SCHEMBL5775676 0.83 PLA2G7 (0.37) ALDH1A1TSHRCYP3A4RAB9AHTR2A
SCHEMBL5773350 0.83 TSHR (0.40) SLC2A1ALDH1A1TSHRCYP3A4LMNA
SCHEMBL5774298 0.81 TSHR (0.42) ALDH1A1KDM4ETSHRHSD17B10LMNA
Trifluoroacetic Acid SCHEMBL5773422 0.81 HSD17B10 (0.43) ACHESLC2A1ALDH1A1KDM4ETSHR
SCHEMBL5777440 0.79 HDAC8 (0.35) KDM4ECYP3A4SMN1; SMN2
SCHEMBL5777116 0.79 CD274 (0.41) ALDH1A1KDM4ETSHRHSD17B10LMNA
SCHEMBL5774897 0.78 MPO (0.35) ALDH1A1HSD17B10CYP3A4LMNAKMT2A
SCHEMBL5775799 0.77 HDAC8 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR ACHE 3102/4885SLC2A1 96/4885ALDH1A1 1045/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 ACHE 3786/4885SLC2A1 47/4885ALDH1A1 682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.